-
England coach McCullum survives review into Ashes drubbing
-
Mixed results for Lyme disease vaccine hit Valneva shares
-
Far-right French president no certainty despite rise of extremes
-
Trump tells AFP 'things are going very well' on Iran
-
Ukraine hits major Russian oil port near Finland
-
EU chief in Australia as trade talks enter 'last mile'
-
UK police probe attack on Jewish ambulances
-
Oil prices slide, European stocks rebound on Trump's Iran remarks
-
Trump announces 'very good' talks with Iran on ending war
-
Arsenal's White gets first England call-up since 2022
-
Greece train tragedy trial adjourned amid courtroom chaos
-
Tottenham face key call as relegation threat grows
-
German court rejects landmark climate case against BMW, Mercedes
-
Trump lifts Iran threat after 'very good' talks on ending war
-
Iran defies Trump Hormuz ultimatum with naval mine threat
-
African players in Europe: Awoniyi seals key win for lowly Forest
-
France ex-PM Lionel Jospin dies aged 88
-
Runway collision kills two pilots, shutters New York airport
-
Hodgkinson in 'shape of her life' with eye on Kratochvilova's record
-
Griezmann given go-ahead to talk with Orlando City
-
Stocks tumble, oil jumps on Trump's Iran ultimatum
-
Mideast war threatens energy crisis worse than 1970s oil shocks
-
Pilot, co-pilot killed in runway collision at New York airport
-
Asian stocks tumble, oil jumps on Trump's Iran ultimatum
-
Plane, fire truck collide on runway at New York's LaGuardia Airport
-
Russia's Max: The unencrypted super-app being forced on citizens
-
EU chief in Australia with eyes on trade deal
-
Asia champions Japan need 'different tools' to win World Cup - coach
-
Global economy under 'major threat' from Strait of Hormuz crisis: IEA chief
-
Planet trapped record heat in 2025: UN
-
Israel launches new strikes on Tehran as Iran takes aim at Gulf sites
-
German court to rule in climate case against automakers
-
France's leftists win mayoral elections in largest cities
-
Cuba restores power grid after latest blackout
-
Asian stocks tumble as Trump gives Iran 48-hour ultimatum
-
Wolves rally past Celtics, Nuggets sink Blazers
-
Middle East war to dominate Houston's 'Davos of Energy'
-
Korda sends Alcaraz to another early exit in Miami, Sabalenka advances
-
Kim holds off Korda charge to win LPGA Founders Cup
-
Slovenia liberal PM claims win over conservatives in tight vote
-
Trump orders immigration agents to airports amid crippling budget standoff
-
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
-
From Chat to Camera: Safer LGBTQ Dating in the Video Era
-
Iran awaits Trump threat to blow up power plants
-
Alcaraz eyes clay court season after early Miami exit
-
Real Madrid down Atletico in derby, leaders Barca edge Rayo
-
Korda sends Alcaraz to another early exit in Miami
-
Bordeaux-Begles hammer Toulouse in Dupont absence
-
Slovenia PM claims election win as results show neck and neck finish
-
England's Fitzpatrick birdies 18th to win PGA Valspar title
Chinese medical portal censored after doubting herbal 'Covid remedy'
A popular Chinese medical information site has been censored by authorities for "violation of relevant laws and regulations", months after its criticism of a government-backed herbal Covid-19 treatment sent shares in a pharmaceutical giant tumbling.
DXY, which counts tech giant Tencent among its investors and runs a host of health-related services, previously questioned the value of Lianhua Qingwen, a herbal remedy marketed for fever and sore throats, as a Covid-19 treatment.
China approved the concoction -- made up of ingredients like honeysuckle and apricot seeds -- as a Covid-19 treatment in 2020, and it was distributed to Shanghai residents during the city's outbreak this year.
DXY's article was part of a wave of reports that caused shares in Lianhua Qingwen's producer -- one of China's largest traditional medicine companies -- to plunge.
The website has now been banned from posting on at least five of its Weibo social media accounts, with a notice at the top of its official page saying that due to "violation of relevant laws and regulations, this user is currently prohibited from posting".
DXY's official WeChat accounts, which typically publish multiple articles a day on medical topics, have not been updated since Monday.
The Weibo notice did not specify which regulations had been violated by DXY, which did not immediately respond to AFP's request for comment.
The Chinese government has increasingly promoted traditional medicine at home and abroad in recent years, often with nationalistic undertones.
DXY's coverage prompted criticism that it was targeting traditional Chinese medicine (TCM) in order to promote Western pharmaceuticals.
The United States and other countries have warned there is no evidence Lianhua Qingwen works to prevent or cure Covid-19, even as it has increasingly been promoted by government authorities in China and Hong Kong.
The US Food and Drug Administration has said it has not approved Lianhua Qingwen and that coronavirus-related claims about it were "not supported by competent and reliable scientific evidence".
Beijing issued its first white paper on TCM in 2016, laying out plans to build medicine centres and dispatch practitioners to developing countries in Africa and Southeast Asia.
President Xi Jinping has described TCM as a "treasure of Chinese civilisation" and has said that it should be given as much weight as other treatments.
Beijing's National Health Commission has also dispatched TCM practitioners as part of its medical reinforcement teams sent to fight Covid-19 outbreaks across the country.
H.Jarrar--SF-PST